国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (2): 166-174.doi: 10.7518/gjkq.2020051

• 论著 • 上一篇    下一篇

经首次根治性手术治疗口腔鳞状细胞癌患者的生存相关影响因素分析

薛伶俐,李雅冬()   

  1. 重庆医科大学附属第一医院颌面外科 重庆 400010
  • 收稿日期:2019-06-25 修回日期:2019-09-30 出版日期:2020-03-01 发布日期:2020-03-12
  • 通讯作者: 李雅冬 E-mail:llxxyydd2006@sina.com
  • 作者简介:薛伶俐,住院医师,硕士,Email: llxue_kq348@163.com
  • 基金资助:
    重庆市科学技术委员会自然科学基金(cstc2018jcyjAX07-63);重庆市卫生与计划生育委员会医学高端后备人才培养项目(2017HBRC004);重庆市教育委员会资助项目(15SKG032)

Survival analysis of patients with oral squamous cell carcinoma treated by radical surgery for the first time

Xue Lingli,Li Yadong()   

  1. Dept. of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
  • Received:2019-06-25 Revised:2019-09-30 Online:2020-03-01 Published:2020-03-12
  • Contact: Yadong Li E-mail:llxxyydd2006@sina.com
  • Supported by:
    This study was supported by Natural Science Foundation Project of Chongqing Science and Technology Committee(cstc2018jcyjAX07-63);Medical High-end Reserve Talent Training Program of Chongqing Health and Family Planning Committee(2017HBRC004);Project of Chongqing Education Commission(15SKG032)

摘要:

目的 分析口腔鳞状细胞癌(OSCC)患者的总体生存率,以及影响生存率的临床病理因素。方法 采集对首次接受根治性外科手术治疗的78例OSCC患者的临床病理及随访资料进行回顾性分析。对计数、计量资料进行描述性分析;采用Kaplan-Meier法绘制生存曲线;采用COX比例风险回归模型进行单因素和多因素分析,分析患者的生存率及预后相关影响因素。结果 最终纳入生存分析的患者共计68例,中位随访时间为63(6~87)个月,5年总体存活率为55.9%,随访期间因OSCC死亡患者的中位生存时间为20.5(6~52)个月。单因素分析表明,临床分期、原发灶大小、淋巴结转移、病理分化及复发转移是影响生存时间的暴露因素(P<0.05);多因素分析表明,病理分化、复发转移是影响生存时间的独立危险因素(P<0.05)。78例OSCC患者中合并发生食道鳞状细胞癌(ESCC)者有4例(5.1%)。结论 根据肿瘤的临床分期(TNM分期)、原发灶大小、淋巴结转移、病理分化及复发转移可对患者的生存预后作出一定的预测,其中病理分化及复发转移是影响生存预后的独立危险因素。有吸烟饮酒史的OSCC患者应常规进行ESCC临床筛查。

关键词: 口腔鳞状细胞癌, 存活率, 预后, 影响因素, 食道鳞状细胞癌

Abstract:

Objective To analyze the overall survival (OS) and relevant risk factors for oral squamous cell carcinoma (OSCC) patients. Methods To retrospectively review the clinical, pathological, and follow-up records of 78 patients after primary radical tumor resection. Descriptive statistics were calculated for each variable, survival was calculated using the Kaplan-Meier method, differences in OS rate were analyzed via a log-rank test, and univariate and multivariate Cox proportional hazard models were performed to analyze the factors associated with overall survival and prognosis. Results A total of 68 patients were included in the final study. The five-year OS rate was 55.9%. The median survival time of the patients who died of this disease within five years was 20.5 (6-52) months. The univariate analysis showed that clinical stage, tumor size, lymph node metastasis, pathological differentiation, recurrence, and metastasis were the exposure factors affecting survival time (P<0.05). Multivariate analysis showed that pathological differentiation, recurrence, and metastasis were in-dependent factors affecting survival time (P<0.05). The patients with esophageal squamous cell carcinoma accounted for 5.1% (4/78) in total 78 OSCC. Conclusion The survival prognosis of patients with oral squamous cell carcinoma is correlated with clinical stage (TNM stage), tumor size, lymph node metastasis, pathological differentiation, recurrence, and metastasis. In this study, pathological differentiation, recurrence, and metastasis were independent factors affecting survival time. Some OSCC patients may be screened for esophageal squamous cell carcinoma.

Key words: oral squamous cell carcinoma, survival rate, prognosis, influence factors, esophageal squamous cell carcinoma

中图分类号: 

  • R730.7

表 1

基线资料及生存相关单因素分析结果"

变量 例数及百分比1) 5年生存情况 COX生存时间单因素分析
生存组(n=38)2) 死亡组(n=30)3) T/χ²检验P
n % B P HR(95%CI)
n % n %
性别 45 66.2 25 65.8 20 66.7 0.939 0.029 0.940 1.029(0.484~2.188)
23 33.8 13 34.2 10 33.3
年龄/岁 60.9±10.64) 58.9±11.15) 63.5±9.66)
≤60 35 51.5 23 60.5 12 40.0 0.093 0.627 0.090 1.872(0.906~3.864)
>60 33 48.5 15 39.5 18 60.0
病程/月 5(3~12)7) 5.5(3~12)8) 4(2~7.5)9) 0.098 -0.068 0.088 0.934(0.864~1.010)
高血压 14 20.6 6 15.8 8 26.7 0.271 0.461 0.262 1.586(0.708~3.553)
54 79.4 32 84.2 22 73.3
糖尿病 9 13.2 7 18.4 2 6.7 0.156 -0.895 0.221 0.409(0.097~1.715)
59 86.8 31 81.6 28 93.3
吸烟 36 52.9 18 47.3 18 60.0 0.300 0.403 0.275 1.496(0.726~3.085)
32 47.1 20 52.6 12 40.0
饮酒 27 39.7 12 31.6 15 50.0 0.123 0.581 0.108 1.788(0.880~3.632)
41 60.3 26 68.4 15 50.0
部位 24 35.3 14 36.8 10 33.3 0.642 0.105 0.406 1.111(0.867~1.423)
21 30.9 14 36.8 7 23.3
牙龈 9 13.2 4 10.5 5 16.7
5 7.4 2 5.3 3 10.0
口底 9 13.2 4 10.5 5 16.7
临床分期 早(Ⅰ、Ⅱ) 33 48.5 23 60.5 10 33.3 0.026 0.858 0.023 2.358(1.126~4.939)
中、晚(Ⅲ、Ⅳ) 35 51.5 15 39.5 20 66.7
T分期 T1 8 11.8 6 15.8 2 6.7 0.141 0.599 0.022 1.820(1.090~3.040)
T2 37 54.4 22 57.9 15 50.0
T3 20 29.4 10 26.3 10 33.3
T4 3 4.4 0 0 3 10.0
淋巴结转移 24 35.3 8 21.1 16 53.3 0.006 1.163 0.001 3.200(1.569~6.524)
44 64.7 30 78.9 14 46.7
病理分化 48 70.6 33 86.8 15 50.0 0.001 1.232 0.001 3.429(1.662~7.077)
中、低 20 29.4 5 13.2 15 50.0
复发转移 32 47.1 29 76.3 3 10.0 <0.001 1.175 <0.001 3.238(2.187~4.796)
原位 14 20.6 7 18.4 7 23.3
颈部 17 25.0 2 5.3 15 50.0
远处 5 7.3 0 0 5 16.7

图 1

68例OSCC患者的总体生存曲线 访止:随访截止时间;生存函数:以时间为自变量,以相应时刻的生存率为函数值的函数,反映每一时刻事件的生存率。"

图 2

临床分期生存曲线"

图 3

原发灶大小生存曲线"

图 4

淋巴结转移生存曲线"

图 5

病理分化生存曲线"

图 6

复发转移生存曲线"

表 2

生存相关多因素分析结果"

变量 B P HR(95%CI)
临床分期 -0.434 0.442 0.648(0.214~1.959)
T分期 0.205 0.527 1.227(0.650~2.315)
淋巴结转移 0.760 0.098 2.139(0.869~5.269)
病理分化 0.958 0.015 2.607(1.205~5.638)
复发转移 1.041 <0.001 2.832(1.851~4.333)
[1] Siegel RL, Miller KD, Jemal A . Cancer statistics, 2016[J]. CA Cancer J Clin, 2016,66(1):7-30.
[2] Götz C, Bissinger O, Nobis C , et al. ALDH1 as a prognostic marker for lymph node metastasis in OSCC[J]. Biomed Rep, 2018,9(4):284-290.
[3] Sasahira T, Kirita T, Kuniyasu H . Update of mole-cular pathobiology in oral cancer: a review[J]. Int J Clin Oncol, 2014,19(3):431-436.
[4] 曹雨庵, 郭伟 . 我国口腔鳞癌的治疗现状[J]. 实用肿瘤杂志, 2012,27(2):109-112.
Cao YA, Guo W . Treatment of oral squamous cell carcinoma in China[J]. J Pract Oncol, 2012,27(2):109-112.
[5] 陈新, 徐文华, 周健 , 等. 口腔鳞状细胞癌现状[J]. 口腔医学, 2017,37(5):462-465.
Chen X, Xu WH, Zhou J , et al. Current situation of oral squamous cell carcinoma[J]. Stomatology, 2017,37(5):462-465.
[6] Chen W, Zheng R, Zuo T , et al. National cancer incidence and mortality in China, 2012[J]. Chin J Cancer Res, 2016,28(1):1-11.
[7] 王倩, 侯大为 . 口腔鳞状细胞癌发病及转移机制研究进展[J]. 口腔医学研究, 2018,34(11):1164-1167.
Wang Q, Hou DW . Research progress in pathogenesis of oral squamous cell carcinoma[J]. J Oral Sci Res, 2018,34(11):1164-1167.
[8] 贺智凤, 蒲玉梅, 胡勤刚 . 口腔鳞状细胞癌切缘状态评估及其影响因素分析[J]. 中华口腔医学杂志, 2017,52(7):445-449.
He ZF, Pu YM, Hu QG . Evaluation and influencing factors of surgical margin status of oral squamous cell carcinoma[J]. Chin J Stomatol, 2017,52(7):445-449.
[9] St John MA . Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma[J]. Laryngoscope, 2015,125(Suppl 3):S1-S11.
[10] Alves AM, Diel LF, Lamers ML . Macrophages and prognosis of oral squamous cell carcinoma: a syste-matic review[J]. J Oral Pathol Med, 2018,47(5):460-467.
[11] de la Oliva J, Larque AB, Marti C , et al. Oral pre-malignant lesions of smokers and non-smokers show similar carcinogenic pathways and outcomes. A clin-icopathological and molecular comparative analysis[J]. J Oral Pathol Med, 2019. DOI: 10.1111/jop.12864.
[12] Kumar B, Cordell KG, Lee JS , et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer[J]. J Clin Oncol, 2008,26(19):3128-3137.
[13] Rivera C . Essentials of oral cancer[J]. Int J Clin Exp Pathol, 2015,8(9):11884-11894.
[14] Wolfer S, Elstner S, Schultze-Mosgau S . Degree of keratinization is an independent prognostic factor in oral squamous cell carcinoma[J]. J Oral Maxillofac Surg, 2018,76(2):444-454.
[15] Chen F, Lin LS, Liu FQ , et al. Three prognostic in-dexes as predictors of response to adjuvant chemora-diotherapy in patients with oral squamous cell carcinoma after radical surgery: a large-scale prospective study[J]. Head Neck, 2019,41(2):301-308.
[16] Weckx A, Riekert M, Grandoch A , et al. Time to re- currence and patient survival in recurrent oral squa-mous cell carcinoma[J]. Oral Oncol, 2019,94:8-13.
[17] 张华, 杨蓉, 叶贝贝 , 等. 389例口腔鳞状细胞癌预后影响因素分析[J]. 天津医科大学学报, 2018,24(4):315-322.
Zhang H, Yang R, Ye BB , et al. Analysis of prognostic factors for 389 patients with oral squamous cell car-cinoma[J]. J Tianjin Med Univ, 2018,24(4):315-322.
[18] Colares N, Souza Rodrigues DF, Freitas MO , et al. Smoking history decreases survival in patients with squamous cell carcinoma of the mouth: a retros-pective study with 15 years of follow-up[J]. Asian Pac J Cancer Prev, 2019,20(6):1781-1787.
[19] Montero PH, Yu CH, Palmer FL , et al. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma[J]. Cancer, 2014,120(2):214-221.
[20] Dissanayaka WL, Pitiyage G, Kumarasiri PV , et al. Clinical and histopathologic parameters in survival of oral squamous cell carcinoma[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012,113(4):518-525.
[21] Asio J, Kamulegeya A, Banura C . Survival and asso-ciated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago hospital, Kam-pala, Uganda[J]. Cancers Head Neck, 2018,3:9.
[22] Taghavi N, Yazdi I . Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histo-logic, genetic and molecular concepts[J]. Arch Iran Med, 2015,18(5):314-319.
[23] Grimm M . Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC[J]. Clin Transl Oncol, 2012,14(11):870-880.
[24] Sandu K, Nisa L, Monnier P , et al. Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis[J]. Acta Otolaryngol, 2014,134(4):416-424.
[25] Kane SV, Gupta M, Kakade AC , et al. Depth of in-vasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity[J]. Eur J Surg Oncol, 2006,32(7):795-803.
[26] Mupparapu M, Shanti RM . Evaluation and staging of oral cancer[J]. Dent Clin North Am, 2018,62(1):47-58.
[27] Kreppel M, Eich HT, Kübler A , et al. Prognostic value of the sixth edition of the UICC’s TNM classi-fication and stage grouping for oral cancer[J]. J Surg Oncol, 2010,102(5):443-449.
[28] Huang TH, Li KY, Choi WS . Lymph node ratio as prognostic variable in oral squamous cell carcinomas: systematic review and meta-analysis[J]. Oral Oncol, 2019,89:133-143.
[29] Yamagata K, Fukuzawa S, Kanno N , et al. Is lymph node ratio a prognostic factor for patients with oral squamous cell carcinoma[J]. J Oral Maxillofac Surg, 2019,77(7):1510-1519.
[30] Ding D, Stokes W, Eguchi M , et al. Association be-tween lymph node ratio and recurrence and survival outcomes in patients with oral cavity cancer[J]. JAMA Otolaryngol Head Neck Surg, 2019,145(1):53-61.
[31] Cuevas Gonzalez JC, Gaitan Cepeda LA, Borges Yanez SA , et al. p53 and p16 in oral epithelial dy-splasia and oral squamous cell carcinoma: a study of 208 cases[J]. Indian J Pathol Microbiol, 2016,59(2):153-158.
[32] Zhuang ZH, Xie N, Hu J , et al. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma[J]. Oncotarget, 2017,8(13):21954-21973.
[33] Safadi RA, Abdullah NI, Alaaraj RF , et al. Clinical and histopathologic prognostic implications of the expression of cytokeratins 8, 10, 13, 14, 16, 18 and 19 in oral and oropharyngeal squamous cell carcinoma[J]. Arch Oral Biol, 2019,99:1-8.
[34] Wang S, Sun M, Gu CW , et al. Expression of CD163, interleukin-10, and interferon-gamma in oral squa-mous cell carcinoma: mutual relationships and pro-gnostic implications[J]. Eur J Oral Sci, 2014,122(3):202-209.
[35] Wang J, Jin X, Liu J , et al. The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma[J]. J Oral Pathol Med, 2017,46(9):766-772.
[36] 黄江峰, 王靖雯, 何保昌 , 等. 口腔鳞状细胞癌患者生存影响因素研究[J]. 中华预防医学杂志, 2016,50(10):880-886.
Huang JF, Wang JW, He BC , et al. Study of survival factors of oral squamous cell carcinoma[J]. Chin J Prev Med, 2016,50(10):880-886.
[37] Wang B, Zhang S, Yue K , et al. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases[J]. Chin J Cancer, 2013,32(11):614-618.
[38] Ghantous Y, Bahouth Z , Abu El-naaj I. Clinical and genetic signatures of local recurrence in oral squa-mous cell carcinoma[J]. Arch Oral Biol, 2018,95:141-148.
[39] Aires FT, Lin CS, Matos LL , et al. Risk factors for distant metastasis in patients with oral cavity squa-mous cell carcinoma undergoing surgical treatment[J]. ORL J Otorhinolaryngol Relat Spec, 2017,79(6):347-355.
[40] Jeon JH, Kim MG, Park JY , et al. Analysis of the outcome of young age tongue squamous cell carc-inoma[J]. Maxillofac Plast Reconstr Surg, 2017,39(1):41.
[41] Luksic I, Suton P, Manojlovic S , et al. Significance of myofibroblast appearance in squamous cell car-cinoma of the oral cavity on the occurrence of occult regional metastases, distant metastases, and survival[J]. Int J Oral Maxillofac Surg, 2015,44(9):1075-1080.
[42] Son HJ, Roh JL, Cho KJ , et al. Nodal factors predic-tive of recurrence and survival in patients with oral cavity squamous cell carcinoma[J]. Clin Otolaryngol, 2018,43(2):470-476.
[43] Noble AR, Greskovich JF, Han J , et al. Risk factors associated with disease recurrence in patients with stage Ⅲ/Ⅳ squamous cell carcinoma of the oral cavity treated with surgery and postoperative radio-therapy[J]. Anticancer Res, 2016,36(2):785-792.
[44] Brandwein-Gensler M, Wei S . Envisioning the next WHO head and neck classification[J]. Head Neck Pathol, 2014,8(1):1-15.
[45] Meng F, Li RF, Ma LY , et al. Porphyromonas gin-givalis promotes the motility of esophageal squa-mous cell carcinoma by activating NF-κB signaling pathway[J]. Microbes Infect, 2019,21(7):296-304.
[46] Smyth EC, Lagergren J, Fitzgerald RC , et al. Oeso-phageal cancer[J]. Nat Rev Dis Primers, 2017,3:17048.
[47] Olsen I, Yilmaz Ö . Possible role of Porphyromonas gingivalis in orodigestive cancers[J]. J Oral Micro-biol, 2019,11(1):1563410.
[48] Ha NH, Woo BH, Kim DJ , et al. Prolonged and re-petitive exposure to Porphyromonas gingivalis in-creases aggressiveness of oral cancer cells by promo-ting acquisition of cancer stem cell properties[J]. Tumor Biol, 2015,36(12):9947-9960.
[49] Matsui T, Okada T, Kawada K , et al. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma pa-tients[J]. Laryngoscope Investig Otolaryngol, 2018,3(4):263-267.
[1] 郝福,宁毅,孙睿,郑晓旭. 口腔鳞状细胞癌中转化因子2β的表达及潜在的临床意义[J]. 国际口腔医学杂志, 2020, 47(2): 159-165.
[2] 董云梅,陶艳,周瑜. 口腔黏膜癌变过程中血清生化标志物的研究进展[J]. 国际口腔医学杂志, 2020, 47(1): 43-50.
[3] 陈宏丽,杨敬,尹刚,李皓缘,乔燕. 锌指蛋白32在口腔鳞状细胞癌中的表达意义及对口腔鳞状细胞癌干细胞的影响[J]. 国际口腔医学杂志, 2019, 46(6): 631-639.
[4] 闫冰,骆献阳,谭迎赟,关丽梅,薛丽丽. 血清表面增强拉曼光谱应用于口腔鳞状细胞癌患者临床分期的研究[J]. 国际口腔医学杂志, 2019, 46(3): 277-281.
[5] 刘玲玲,刘树泰. 上颌腭侧软组织厚度的测量方法及影响因素[J]. 国际口腔医学杂志, 2019, 46(2): 234-237.
[6] 李群,关为群,张杨安,黄志超. 骨膜蛋白和p53在口腔白斑及鳞状细胞癌组织中的表达及意义[J]. 国际口腔医学杂志, 2019, 46(1): 5-11.
[7] 李媛媛,程斌,王韵. 长链非编码RNA lnc-p26090对口腔鳞状细胞癌细胞糖酵解及增殖的影响[J]. 国际口腔医学杂志, 2018, 45(6): 628-634.
[8] 王伊婷,何永文. 口腔鳞状细胞癌相关长链非编码RNA调控肿瘤细胞上皮-间充质转化的研究进展[J]. 国际口腔医学杂志, 2018, 45(6): 635-639.
[9] 方川,李雅冬. 微小RNA在口腔鳞状细胞癌中的研究进展[J]. 国际口腔医学杂志, 2018, 45(6): 646-651.
[10] 赵金,赖光云,汪俊. 全身麻醉下儿童口腔疾病治疗家长接受度现况的研究进展[J]. 国际口腔医学杂志, 2018, 45(6): 739-744.
[11] 余芯乐, 郑军, 徐江, 曾妍. 口腔鳞状细胞癌患者唾液和血清中N-α-乙酰基转移酶10的水平及其临床意义[J]. 国际口腔医学杂志, 2018, 45(4): 391-395.
[12] 李锦锦, 潘剑. 自体牙移植及其结合正畸治疗的研究进展[J]. 国际口腔医学杂志, 2018, 45(1): 91-96.
[13] 杜书芳, 唐华. 糖尿病患者种植义齿临床预后评估体系的建立及相关护理[J]. 国际口腔医学杂志, 2017, 44(5): 555-558.
[14] 徐晶, 张晓蓉. 正畸治疗对上气道形态影响的研究进展[J]. 国际口腔医学杂志, 2017, 44(5): 544-449.
[15] 王琨,葛奕辰,崔博淼,苟雅萍,孙崇奎,龙敏,肖丽,英李燕. 端粒酶卡侯体蛋白1干扰慢病毒对口腔鳞状细胞癌细胞裸鼠致瘤作用的研究[J]. 国际口腔医学杂志, 2017, 44(1): 32-36.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 王昆润. 二甲亚砜和双氯芬酸并用治疗根尖周炎[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 汤庆奋,王学侠. 17β-雌二醇对人类阴道和口腔颊粘膜的渗透性[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 潘劲松. 颈总动脉指压和颈内动脉球囊阻断试验在大脑血液动力学中的不同影响[J]. 国际口腔医学杂志, 1999, 26(05): .
[4] 王昆润. 后牙冠根斜形牙折的治疗[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 杨锦波. 嵌合体防龋疫苗的研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 王昆润. 下颔骨成形术用网状钛板固定植骨块[J]. 国际口腔医学杂志, 1999, 26(04): .
[7] 汪月月,郭莉莉. 口腔机能与老化—痴呆危险因素流行病学研究[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 田磊. 局部应用脂多糖后结合上皮反应性增生的变化[J]. 国际口腔医学杂志, 1999, 26(04): .
[9] 戴青. 口腔念珠菌病的新分类[J]. 国际口腔医学杂志, 1999, 26(04): .
[10] 王金涛 刘美娟 孙宏晨 欧阳喈. 牙槽嵴牵张成骨[J]. 国际口腔医学杂志, 2004, 31(02): 146 -148 .